The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Charcot‐marie‐tooth disease subtypes and genetic testing strategies
Open accessAbstract
Objective: Charcot‐Marie‐Tooth disease (CMT) affects 1 in 2,500 people and is caused by mutations in more than 30 genes. Identifying the genetic cause of CMT is often necessary for family planning, natural history studies, and for entry into clinical trials. However genetic testing can be both expensive and confusing to patients and physicians. Methods: We analyzed data from 1,024 of our patients to determine the percentage and features of each CMT subtype within this clinic population. We identified distinguishing clinical and physiological features of the subtypes that could be used to direct genetic testing for patients with CMT. Results: Of 1,024 patients evaluated, 787 received CMT diagnoses. A total of 527 patients with CMT (67%) received a genetic subtype, while 260 did not have a mutation identified. The most common CMT subtypes were CMT1A, CMT1X, hereditary neuropathy with liability to pressure palsies (HNPP), CMT1B, and CMT2A. All other subtypes accounted for less than 1% each. Eleven patients had >1 genetically identified subtype of CMT. Patients with genetically identified CMT were separable into specific groups based on age of onset and the degree of slowing of motor nerve conduction velocities. Interpretation: Combining features of the phenotypic and physiology groups allowed us to identify patients who were highly likely to have specific subtypes of CMT. Based on these results, we propose a strategy of focused genetic testing for CMT, illustrated in a series of flow diagrams created as testing guides. ANN NEUROL 2011;69:22–33.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
Züchner, S., Mersiyanova, I. V., Muglia, M., Bissar-Tadmouri, N., Rochelle, J., Dadali, E. L., Zappia, M., Nelis, E., Patitucci, A., Senderek, J., et al. (2004) · Nature Genetics · doi:10.1038/ng1341 · Cited by 1,572
Genetic and clinical aspects of Charcot‐Marie‐Tooth's disease
Skre, H. (1974) · Clinical Genetics · doi:10.1111/j.1399-0004.1974.tb00638.x · Cited by 906
THE CLINICAL FEATURES OF HEREDITARY MOTOR AND SENSORY NEUROPATHY TYPES I AND II
Harding, A. E. B., & Thomas, P. K. (1980) · Brain · doi:10.1093/brain/103.2.259 · Cited by 838
Nelis, E., & Van Broeckhoven, C. (1996) · European Journal of Human Genetics · doi:10.1159/000472166 · Cited by 431
Neurological dysfunction and axonal degeneration in Charcot-Marie-Tooth disease type 1A
Krajewski, K. M. (2000) · Brain · doi:10.1093/brain/123.7.1516 · Cited by 414
MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2
Verhoeven, K. (2006) · Brain · doi:10.1093/brain/awl126 · Cited by 409
England, J. D., Gronseth, G. S., Franklin, G., Carter, G. T., Kinsella, L. J., Cohen, J. A., Asbury, A. K., Szigeti, K., Lupski, J. R., Latov, N., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000336345.70511.0f · Cited by 324
Phenotypic clustering in MPZ mutations
Shy, M. E. (2004) · Brain · doi:10.1093/brain/awh048 · Cited by 298
Self-citationEngland, J. D., Gronseth, G. S., Franklin, G., Carter, G. T., Kinsella, L. J., Cohen, J. A., Asbury, A. K., Szigeti, K., Lupski, J. R., Latov, N., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000336370.51010.a1 · Cited by 272
Mitochondrial GTPase mitofusin 2 mutation in Charcot?Marie?Tooth neuropathy type 2A
Kijima, K., Numakura, C., Izumino, H., Umetsu, K., Nezu, A., Shiiki, T., Ogawa, M., Ishizaki, Y., Kitamura, T., Shozawa, Y., et al. (2005) · Human Genetics · doi:10.1007/s00439-004-1199-2 · Cited by 251
England, J. D., Gronseth, G. S., Franklin, G., Carter, G. T., Kinsella, L. J., Cohen, J. A., Asbury, A. K., Szigeti, K., Lupski, J. R., Latov, N., et al. (2009) · PM&R · doi:10.1016/j.pmrj.2008.11.011 · Cited by 192
Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene
Lawson, V. H., Graham, B. V., & Flanigan, K. M. (2005) · Neurology · doi:10.1212/01.wnl.0000168898.76071.70 · Cited by 183
CMT1X phenotypes represent loss of GJB1 gene function
Shy, M. E., Siskind, C. E., Swan, E. R., Krajewski, K. M., Doherty, T. J., Fuerst, D. R., Ainsworth, P., Lewis, R. A., Scherer, S. S., & Hahn, A. F. (2007) · Neurology · doi:10.1212/01.wnl.0000256709.08271.4d · Cited by 156
Self-citationEngland, J. D., Gronseth, G., Franklin, G. M., Carter, G. T., Kinsella, L. J., Cohen, J. A., Asbury, A. K., Szigeti, K., Lupski, J. R., Latov, N., et al. (2009) · PM&R · doi:10.1016/j.pmrj.2008.11.010 · Cited by 143
Neuropathy progression in Charcot-Marie-Tooth disease type 1A
Shy, M. E., Chen, L., Swan, E. R., Taube, R. R., Krajewski, K. M., Herrmann, D. N., Lewis, R. A., & McDermott, M. (2008) · Neurology · doi:10.1212/01.wnl.0000297553.36441.ce · Cited by 132
Self-citationShy, M. E., Lupski, J. R., Chance, P. F., Klein, C. J., & Dyck, P. J. (2005) · Elsevier eBooks · doi:10.1016/b978-0-7216-9491-7.50072-7 · Cited by 124
Self-citationAutosomal-Recessive Forms of Demyelinating Charcot-Marie-Tooth Disease
Dubourg, O., Azzedine, H., Verny, C., Durosier, G., Birouk, N., Gouider, R., Salih, M. A. M., Bouhouche, A., Thiam, A., Grid, D., et al. (2006) · NeuroMolecular Medicine · doi:10.1385/nmm:8:1-2:75 · Cited by 97
Weiss, J. M. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7506-7431-7.50021-x · Cited by 95
Loss‐of‐function phenotype of hereditary neuropathy with liability to pressure palsies
Li, J., Krajewski, K. M., Lewis, R. A., & Shy, M. E. (2003) · Muscle & Nerve · doi:10.1002/mus.10521 · Cited by 71
Self-citationEngland, J. D., Gronseth, G., Franklin, G. M., Carter, G. T., Kinsella, L. J., Cohen, J. A., Asbury, A. K., Szigeti, K., Lupski, J. R., Latov, N., et al. (2008) · Muscle & Nerve · doi:10.1002/mus.21226 · Cited by 69
Cited by
Mitochondrial dynamics in health and disease: mechanisms and potential targets
Chen, W., Zhao, H., & Li, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01547-9 · Cited by 1,306
Disturbed mitochondrial dynamics and neurodegenerative disorders
Burté, F., Carelli, V., Chinnery, P. F., & Yu-Wai-Man, P. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.228 · Cited by 660
Charcot–Marie–Tooth disease: frequency of genetic subtypes and guidelines for genetic testing
Murphy, S. M., Laura, M., Fawcett, K., Pandraud, A., Liu, Y.-T., Davidson, G. L., Rossor, A. M., Polke, J. M., Castleman, V., Manji, H., et al. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-302451 · Cited by 378
Clinical implications of genetic advances in Charcot–Marie–Tooth disease
Rossor, A. M., Polke, J. M., Houlden, H., & Reilly, M. M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.179 · Cited by 358
Fridman, V, Bundy, B., Reilly, M. M., Pareyson, D., Bacon, C., Burns, J., Day, J., Feely, S., Finkel, R. S., Grider, T., et al. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2014-308826 · Cited by 354
Self-citation
Metadata
- Authors
- Saporta, A. S. D., Sottile, S. L., Miller, L. J., Feely, S. M. E., Siskind, C. E., & Shy, M. E.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 69
- Issue
- 1
- Pages
- 22-33
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2012859692
- Cited by
- 542
- References
- 21
- FWCI
- 18.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.